Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics, Safety, and Tolerability of TR-701 Free Acid (FA) in Elderly Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects in the following groups: An elderly subject at least 65 years of age. At least 5 subjects must be at least 75 years of age OR A matched-control subject between 18 and 45 years of age, inclusive~* BMI ≥18.0 kg/m2 and ≤35.0 kg/m2~Elderly Group~* Medical history, physical examination, and laboratory results consistent with stable health (as determined by the Investigator)~Control Group~* Medically stable with no clinically significant abnormalities~Exclusion Criteria:~* Significant, uncontrolled, or life-threatening condition or organ or system condition or disease (eg, impaired cognitive status, respiratory insufficiency, advanced malnutrition)~* Positive hepatitis B surface antigen, hepatitis C virus antibody, or human immunodeficiency virus antibody test result~* Previous inclusion in a TR-701 FA or TR-701 clinical study~* ECG finding of QTc interval \>500 msec, or other clinically significant ECG abnormality at Screening~* Female subjects whom are pregnant, lactating or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Elderly subjects (65 or older) (Type: EXPERIMENTAL): None
- Younger adults (18-45 years old) (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).